Skip to content
MedsAcross

Brand family

Sunosi

Solriamfetol · Axsome Therapeutics
United States
Presentations
2
Markets
1

Sunosi is a brand of Solriamfetol marketed by Axsome Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Solriamfetol
Brand owner
Axsome Therapeutics
Registered in
United States
Strengths and forms
150 mg tablet, 75 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Sunosi 150 mg tabletOralAxsome TherapeuticsUS FDAAvailable on request
Sunosi 75 mg tabletOralAxsome TherapeuticsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Sunosi

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.